Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000473

Type of data
NGS (WGS, Exome)
Access criteria
Controlled-access (Type I)
Total data volume
13.2 TB
File formats
  • FASTQ
Research
hum0291
Date published
2021-12-10
Date modified
2023-09-08

Analysis method

WGS

Materials and participants
Pancreatic tumor (ICD10: C25): 33 cases
Duodenal tumor (ICD10: C170): 2 cases
Biliary tumors (ICD10: C240): 1 case
  • Health status
    Affected
  • Subject count
    36 (Individual)
Disease
Pancreatic tumor (C25)
Duodenal tumor (C170)
Biliary tumors (C240)
Sample description
DNAs extracted from frozen samples (tumor and matched non-tumor tissues)
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WGS
Target
N/A
Reagent kit
TruSeq DNA PCR-Free Library Prep Kit
Fragmentation
Ultrasonic fragmentation (Covaris S2 or E220ev)
Platform
Illumina HiSeq 2000
Illumina HiSeq 2500
Read type
Paired-end
Read length
100 bp

WES

Materials and participants
Pancreatic tumor (ICD10: C25): 24 cases
Duodenal tumor (ICD10: C170): 4 cases
Biliary tumors (ICD10: C240): 10 cases
  • Health status
    Affected
  • Subject count
    38 (Individual)
Disease
Pancreatic tumor (C25)
Duodenal tumor (C170)
Biliary tumors (C240)
Sample description
DNAs extracted from FFPE samples (tumor and matched non-tumor tissues)
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
TruSeq Exome Library Prep Kit
Fragmentation
Ultrasonic fragmentation (Covaris S2 or E220ev)
Platform
Illumina HiSeq 2000
Illumina HiSeq 2500
Read type
Paired-end
Read length
100 bp

RNA-seq

Materials and participants
Pancreatic tumor (ICD10: C25): 43 cases
tumor tissue: 43 samples, non-tumor tissue: 3 samples
Duodenal tumor (ICD10: C170): 4 cases
tumor tissue: 5 samples, non-tumor tissue: 1 sample
Biliary tumors (ICD10: C240): 1 case
tumor tissue: 1 sample
  • Health status
    Affected
  • Subject count
    48 (Individual)
Disease
Pancreatic tumor (C25)
Duodenal tumor (C170)
Biliary tumors (C240)
Sample description
RNAs extracted from tumor or non-tumor tissues
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq RNA Exome
Fragmentation
N/A
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
100 bp